Document Detail

Role of gallium arsenide laser irradiation at 890 nm as an adjunctive to anti-tuberculosis drugs in the treatment of pulmonary tuberculosis.
MedLine Citation:
PMID:  12683708     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Tuberculosis is a global emergency with about nine million people developing disease every year. The long duration of treatment has emerged as a major obstacle in the control of tuberculosis. There is a need for development of new drugs and or shortened therapy. METHODS: The present study was carried out to explore whether any benefit could be achieved by the addition of low level energy laser therapy (LLLT) to the conventional anti-tubercular chemotherapy. One-hundred-thirty new sputum smear positive patients of pulmonary tuberculosis were enrolled to evaluate the bio-stimulatory effects of Gallium Arsenide laser irradiation at 890 nm, as an adjuvant therapy. These patients were randomly divided into two groups to receive either LLLT or sham irradiation (control) concomitantly with anti-tuberculosis chemotherpy. RESULTS: The patients treated with semiconductor laser as an adjuvant therapy along with anti-tuberculosis drugs had a faster clearance of tubercle bacilli from the sputum as compared to the control group (P value at :45 days=0.1392, 60 days=0.0117, 75 days=0.00805, 90 days=0.00739). CONCLUSIONS: These findings provide preliminary evidence that low level laser therapy with Gallium Arsenide laser may be a promising adjunctive therapy for patients with tuberculosis. Faster conversion of sputum should prevent the development of resistant mutants.
M M Puri; V K Arora
Related Documents :
16096078 - Are psychodynamic and psychoanalytic therapies effective?: a review of empirical data.
12520888 - The role of couple therapy in the treatment of narcissistic personality disorder.
14750048 - Effect of risperidone on prolactinoma--a case report.
8103148 - Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiourac...
24021218 - Psychiatric correlates of alcohol and tobacco use disorders in u.s. adults aged 65 year...
25280168 - A bright side, facet analysis of histrionic personality disorder: the relationship betw...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Indian journal of chest diseases & allied sciences     Volume:  45     ISSN:  0377-9343     ISO Abbreviation:  Indian J Chest Dis Allied Sci     Publication Date:    2003 Jan-Mar
Date Detail:
Created Date:  2003-04-09     Completed Date:  2003-05-30     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7612044     Medline TA:  Indian J Chest Dis Allied Sci     Country:  India    
Other Details:
Languages:  eng     Pagination:  19-23     Citation Subset:  IM    
Department of Tuberculosis and Chest Diseases, LRS Institute of Tuberculosis and Allied Diseases, Sri Aurobindo Marg, New Delhi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antitubercular Agents / administration & dosage
Combined Modality Therapy
Laser Therapy, Low-Level*
Tuberculosis, Pulmonary / drug therapy,  radiotherapy,  therapy*
Reg. No./Substance:
0/Antitubercular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.
Next Document:  Pulmonary functions in patients with epidemic dropsy.